The preclinical efficacy of the novel hypomethylating agent NTX-301 as a monotherapy and in combination with venetoclax in acute myeloid leukemia

• Byungho Lim,
• Dabin Yoo,
• Younghwa Chun,
• Areum Go,
• Kyung-Jin Cho,
• Daeun Choi,
• Myoung Eun Jung,
• Ha Young Lee,
• Rebecca J. Boohaker,
• Jin Soo Lee,
• DooYoung Jung,
• Gildon Choi

Affiliations

Byungho Lim

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology

Dabin Yoo

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology

Younghwa Chun

Pinotbio, Inc

Areum Go

Pinotbio, Inc

Kyung-Jin Cho

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology

Daeun Choi

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology

Myoung Eun Jung

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology

Ha Young Lee

Pinotbio, Inc

Rebecca J. Boohaker

Southern Research, Division of Drug Discovery

Jin Soo Lee

Pinotbio, Inc

DooYoung Jung

Pinotbio, Inc

Gildon Choi

Research Center for Drug Discovery Technology, Korea Research Institute of Chemical Technology